Antonio Maria Risitano
European Society for Blood and Marrow Transplantation · 460 works · 16,688 citations · h-index 67
Top works
- The Complement Inhibitor Eculizumab in Paroxysmal Nocturnal Hemoglobinuria
- Multicenter phase 3 study of the complement inhibitor eculizumab for the treatment of patients with paroxysmal nocturnal hemoglobinuria
- Effect of the complement inhibitor eculizumab on thromboembolism in patients with paroxysmal nocturnal hemoglobinuria
- Antilymphocyte Globulin for Prevention of Chronic Graft-versus-Host Disease
- Complement as a target in COVID-19?
- Long‐term safety and efficacy of sustained eculizumab treatment in patients with paroxysmal nocturnal haemoglobinuria
- Complement fraction 3 binding on erythrocytes as additional mechanism of disease in paroxysmal nocturnal hemoglobinuria patients treated by eculizumab
- Paroxysmal Nocturnal Hemoglobinuria
- Distinct clinical outcomes for cytogenetic abnormalities evolving from aplastic anemia
- Ravulizumab (ALXN1210) vs eculizumab in C5-inhibitor–experienced adult patients with PNH: the 302 study
- Influence of loop size on the stability of intramolecular DNA quadruplexes
- Pegcetacoplan versus Eculizumab in Paroxysmal Nocturnal Hemoglobinuria
- Eculizumab in Pregnant Patients with Paroxysmal Nocturnal Hemoglobinuria
- In-vivo dominant immune responses in aplastic anaemia: molecular tracking of putatively pathogenetic T-cell clones by TCR β-CDR3 sequencing
- The first case of COVID-19 treated with the complement C3 inhibitor AMY-101
- Eltrombopag Added to Immunosuppression in Severe Aplastic Anemia
- Anti-complement Treatment for Paroxysmal Nocturnal Hemoglobinuria: Time for Proximal Complement Inhibition? A Position Paper From the SAAWP of the EBMT
- The management of pregnancy in paroxysmal nocturnal haemoglobinuria on long term eculizumab
- Prospective study of rabbit antithymocyte globulin and cyclosporine for aplastic anemia from the EBMT Severe Aplastic Anaemia Working Party
- Infections by carbapenem-resistant Klebsiella pneumoniae in SCT recipients: a nationwide retrospective survey from Italy